Watson Pharmaceuticals, Inc. Reports Third Quarter 2004 Financial Results

Seattle Genetics, Inc. (Nasdaq:SGEN) today reported financial results for its third quarter and nine months ended September 30, 2004.
MORE ON THIS TOPIC